Valion Bio Inc stock is traded at $0.502, with a volume of 112,691. It is down -2.92% in the last 24 hours and down -78.91% over the past month. Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
Previous Close:
$0.5171
Open:
$0.52
24h Volume:
112,691
Relative Volume:
0.06
Market Cap:
$1.05M
Revenue:
$232.00K
Net Income/Loss:
-$12.13M
P/E Ratio:
-
EPS:
-$8.95
Net Cash Flow:
-$10.29M
1W Performance:
-8.73%
1M Performance:
-78.91%
6M Performance:
-98.05%
1Y Performance:
0.00%
1-Day Range:
$0.00$0.00
1-Week Range:
$0.4715$0.584
52-Week Range:
$0.4715$32.50
Valion Bio Inc Stock (VBIO) Company Profile
Name
Valion Bio IncSector
HealthcareIndustry
BiotechnologyPhone
(888)276-6888Address
1305 E. HOUSTON STREET, SAN ANTONIO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS